Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Inhibition of glioma invasion by overexpression of pigment epithelium-derived factor

Abstract

Pigment epithelium-derived factor (PEDF) is a potent inhibitor of angiogenesis and an inducer of neural differentiation. We previously reported the loss of PEDF expression in glioma progression. In this study, we investigated whether PEDF overexpression could suppress glioma growth and invasion. Glioma cell line U251 was stably transfected with a full-length human PEDF expression vector. The expression and release of various cytokines and angiogenic factors into the medium were analyzed by real-time reverse transcription-polymerase chain reaction, enzyme-linked immunosorbent assay, and gelatin zymography. Apoptosis was checked by terminal deoxynucleotidyl transferase-mediated dUTP nick end labeling. Growth inhibition was evaluated by using the in vitro Matrigel invasion. Tumorigenicity was examined in vivo by subcutaneous xenotransplantation into severe combined immunodeficient mice. In U251 cells overexpressing PEDF, thrombospondin-1 protein was upregulated (5.3-fold more), but the production of vascular endothelial growth factor (VEGF) (1.8-fold less) and basic fibroblast growth factor (2.5-fold less) was lower than in cells transfected with the vector only. PEDF also downregulated the production of matrix metalloproteinase-9. Conditioned medium collected from the PEDF-transfected U251 cells showed a significant reduction of VEGF expression. In vitro invasiveness was reduced by approximately 40%. PEDF expression prevented the growth of transfected cells and caused a significant increase in the percentage of cells undergoing apoptosis (50.4% in PEDF-transfected cells). Furthermore, the size of xenotransplants was significantly smaller. In conclusion, PEDF overexpression decreased malignancy, and this might be attributed to the promotion of apoptosis and the regulation of expression of angiogenic effectors. Thus, treatment with PEDF may be useful in patients with malignant gliomas. However, the mechanism of apoptosis induction needs to be investigated.

This is a preview of subscription content, access via your institution

Access options

Rent or buy this article

Prices vary by article type

from$1.95

to$39.95

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
Figure 6
Figure 7

Similar content being viewed by others

References

  1. Tombran-Tink J, Chader GG, Johnson LV . PEDF: a pigment epithelium-derived factor with potent neuronal differentiative activity. Exp Eye Res. 1991;53:411–414.

    Article  CAS  PubMed  Google Scholar 

  2. Becerra SP, Palmer I, Kumar A, et al. Overexpression of fetal human pigment epithelium-derived factor in Escherichia coli. A functionally active neurotrophic factor. J Biol Chem. 1993;268:23148–23156.

    CAS  PubMed  Google Scholar 

  3. Steele FR, Chader GJ, Johnson LV, et al. Pigment epithelium-derived factor: neurotrophic activity and identification as a member of the serine protease inhibitor gene family. Proc Natl Acad Sci USA. 1993;90:1526–1530.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  4. Tombran-Tink J, Mazuruk K, Rodriguez IR, et al. Organization, evolutionary conservation, expression and unusual Alu density of the human gene for pigment epithelium-derived factor, a unique neurotrophic serpin. Mol Vis. 1996;2:11–15.

    CAS  PubMed  Google Scholar 

  5. Taniwaki T, Becerra SP, Chader GJ, et al. Pigment epithelium-derived factor is a survival factor for cerebellar granule cells in culture. J Neurochem. 1995;64:2509–2517.

    Article  CAS  PubMed  Google Scholar 

  6. Seigel GM, Tombran-Tink J, Becerra SP, et al. Differentiation of Y79 retinoblastoma cells with pigment epithelial-derived factor and interphotoreceptor matrix wash: effects on tumorigenicity. Growth Factors. 1994;10:289–297.

    Article  CAS  PubMed  Google Scholar 

  7. Cao W, Tombran-Tink J, Chen W, et al. Pigment epithelium-derived factor protects cultured retinal neurons against hydrogen peroxide-induced cell death. J Neurosci Res. 1999;57:789–800.

    Article  CAS  PubMed  Google Scholar 

  8. Dawson DW, Volpert OV, Gillis P, et al. Pigment epithelium-derived factor: a potent inhibitor of angiogenesis. Science. 1999;285:245–248.

    Article  CAS  PubMed  Google Scholar 

  9. Sugita Y, Becerra SP, Chader GJ, et al. Pigment epithelium-derived factor (PEDF) has direct effects on the metabolism and proliferation of microglia and indirect effects on astrocytes. J Neurosci Res. 1997;49:710–718.

    Article  CAS  PubMed  Google Scholar 

  10. Bilak MM, Corse AM, Bilak SR, et al. Pigment epithelium-derived factor (PEDF) protects motor neurons from chronic glutamate-mediated neurodegeneration. J Neuropathol Exp Neurol. 1999;58:719–728.

    Article  CAS  PubMed  Google Scholar 

  11. Kuncl RW, Bilak MM, Bilak SR, et al. Pigment epithelium-derived factor is elevated in CSF of patients with amyotrophic lateral sclerosis. J Neurochem. 2002;81:178–184.

    Article  CAS  PubMed  Google Scholar 

  12. Crawford SE, Stellmach V, Ranalli M, et al. Pigment epithelium-derived factor (PEDF) in neuroblastoma: a multifunctional mediator of Schwann cell antitumor activity. J Cell Sci. 2001;114(Part 24):4421–4428.

    CAS  PubMed  Google Scholar 

  13. Guan M, Yam HF, Su B, et al. Loss of pigment epithelium-derived factor expression in glioma progression. J Clin Pathol. 2003;56:277–282.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  14. Nicholas MK, Prados MD, Larson DA, et al. Malignant astrocytomas in cancer of the nervous system. Oxford: Blackwell. 1997;464–491.

    Google Scholar 

  15. Semkova I, Kreppel F, Welsandt G, et al. Autologous transplantation of genetically modified iris pigment epithelial cells: a promising concept for the treatment of age-related macular degeneration and other disorders of the eye. Proc Natl Acad Sci USA. 2002;99:13090–13095.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  16. Raisler BJ, Berns KI, Grant MB, et al. Adeno-associated virus type-2 expression of pigmented epithelium-derived factor or Kringles 1–3 of angiostatin reduce retinal neovascularization. Proc Natl Acad Sci USA. 2002;99:8909–8914.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  17. Mori K, Gehlbach P, Ando A, et al. Regression of ocular neovascularization in response to increased expression of pigment epithelium-derived factor. Invest Ophthalmol Vis Sci. 2002;43:2428–2434.

    PubMed  Google Scholar 

  18. Kirsch M, Strasser J, Allende R, et al. Angiostatin suppresses malignant glioma growth in vivo. Cancer Res. 1998;58:4654–4659.

    CAS  PubMed  Google Scholar 

  19. Nguyen JT, Wu P, Clouse ME, et al. Adeno-associated virus-mediated delivery of antiangiogenic factors as an antitumor strategy. Cancer Res. 1998;58:5673–5677.

    CAS  PubMed  Google Scholar 

  20. Auguste P, Gursel DB, Lemiere S, et al. Inhibition of fibroblast growth factor/fibroblast growth factor receptor activity in glioma cells impedes tumor growth by both angiogenesis-dependent and -independent mechanisms. Cancer Res. 2001;61:1717–1726.

    CAS  PubMed  Google Scholar 

  21. Nakada M, Okada Y, Yamashita J . The role of matrix metalloproteinases in glioma invasion. Front Biosci. 2003;8:E261–E269.

    Article  CAS  PubMed  Google Scholar 

  22. Rao JS, Steck PA, Mohanam S, et al. Elevated levels of M(r) 92,000 type IV collagenase in human brain tumors. Cancer Res. 1993;53(10 Suppl):2208–2211.

    CAS  PubMed  Google Scholar 

  23. Kugler W, Erdlenbruch B, Junemann A, et al. Erucylphosphocholine-induced apoptosis in glioma cells: involvement of death receptor signalling and caspase activation. J Neurochem. 2002;82:1160–1170.

    Article  CAS  PubMed  Google Scholar 

  24. Tatter SB . Recurrent malignant glioma in adults. Curr Treat Options Oncol. 2002;3:509–524.

    Article  PubMed  Google Scholar 

  25. Araki T, Taniwaki T, Becerra SP, et al. Pigment epithelium-derived factor (PEDF) differentially protects immature but not mature cerebellar granule cells against apoptotic cell death. J Neurosci Res. 1998;53:7–15.

    Article  CAS  PubMed  Google Scholar 

  26. Taniwaki T, Hirashima N, Becerra SP, et al. Pigment epithelium-derived factor protects cultured cerebellar granule cells against glutamate-induced neurotoxicity. J Neurochem. 1997;68:26–32.

    Article  CAS  PubMed  Google Scholar 

  27. Hutchings H, Maitre-Boube M, Tombran-Tink J, et al. Pigment epithelium-derived factor exerts opposite effects on endothelial cells of different phenotypes. Biochem Biophys Res Commun. 2002;294:764–769.

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgements

We thank Mr Yuming Chen, Ms Xiu-Ling Ji, and Ms Xue-Fang Shen for excellent technical support, and Dr Ming Xu for helpful discussion. This work was supported in part by Natural Science Foundation of China (No.30300360).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Yuan Lu.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Guan, M., Pang, CP., Yam, HF. et al. Inhibition of glioma invasion by overexpression of pigment epithelium-derived factor. Cancer Gene Ther 11, 325–332 (2004). https://doi.org/10.1038/sj.cgt.7700675

Download citation

  • Received:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.cgt.7700675

Keywords

This article is cited by

Search

Quick links